Literature DB >> 34346004

Initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease presenting with unilateral exudative retinal detachment despite bilateral choroidal involvement.

Abdulrahman F AlBloushi1, Carl P Herbort2, Ahmed M Abu El-Asrar3,4.   

Abstract

PURPOSE: To investigate the frequency of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada (VKH) disease presenting with unilateral exudative retinal detachment.
METHODS: A retrospective case series.
RESULTS: During the period between January 1998 and December 2020, we identified 135 patients with initial-onset acute uveitis associated with VKH disease. Among them, 5 (3.7%) patients were referred to have unilateral uveitis due to the presence of exudative retinal detachment in only one eye. Optical coherence tomography confirmed the presence of unilateral exudative retinal detachment, however, indocyanine green angiography (ICGA) revealed characteristic findings of bilateral granulomatous choroidal inflammation typical for initial-onset acute uveitis associated with VKH disease.
CONCLUSIONS: Patients with initial-onset acute uveitis associated with VKH disease can present with unilateral exudative retinal detachment. ICGA assessment of the choroid revealed the presence of subclinical involvement of the fellow eyes.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Exudative retinal detachment; Indocyanine green angiography; Unilateral; Uveitis; Vogt-Koyanagi-Harada disease

Year:  2021        PMID: 34346004     DOI: 10.1007/s10792-021-01989-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  22 in total

1.  Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats.

Authors:  K Yamaki; I Kondo; H Nakamura; M Miyano; S Konno; S Sakuragi
Journal:  Exp Eye Res       Date:  2000-10       Impact factor: 3.467

2.  Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease.

Authors:  K Gocho; I Kondo; K Yamaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-08       Impact factor: 4.799

3.  Early manifestation of vogt-koyanagi-harada disease as unilateral posterior scleritis.

Authors:  Noriko Kouda; Hiroshi Sasaki; Sachiko Harada; Yoshihisa Yamada; Nobuo Takahashi; Kazuyuki Sasaki
Journal:  Jpn J Ophthalmol       Date:  2002 Sep-Oct       Impact factor: 2.447

4.  Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease.

Authors:  K Yamaki; K Gocho; K Hayakawa; I Kondo; S Sakuragi
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

5.  Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.

Authors:  Peizeng Yang; Yalin Ren; Bing Li; Wang Fang; Qianli Meng; Aize Kijlstra
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

Review 6.  Vogt-koyanagi-harada syndrome.

Authors:  Wang Fang; Peizeng Yang
Journal:  Curr Eye Res       Date:  2008-07       Impact factor: 2.424

7.  Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.

Authors:  Ahmed M Abu El-Asrar; Mamdouh Al Tamimi; Suhail Hemachandran; Hani S Al-Mezaine; Abdulrahman Al-Muammar; Dustan Kangave
Journal:  Acta Ophthalmol       Date:  2013-04-10       Impact factor: 3.761

8.  Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.

Authors:  Edmund Tsui; Alexander Bottini; Quraish Ghadiali; Chandrakumar Balaratnasingam; Irene Barbazetto
Journal:  Ocul Immunol Inflamm       Date:  2017-10-11       Impact factor: 3.070

9.  Unilateral Presentation of Vogt-Koyanagi-Harada Syndrome.

Authors:  Seyedeh Maryam Hosseini; Maryam Dourandish; Marjan Mazouchi
Journal:  J Ophthalmic Vis Res       Date:  2020-02-02

10.  Recurrent Unilateral Vogt-Koyanagi-Harada Disease with Posterior Scleritis.

Authors:  Su Young Moon; Won Tae Yoon; Sung Pyo Park
Journal:  Korean J Ophthalmol       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.